Head Title

The 10 Common Evidence-Supported Indications for MEG in Epilepsy Surgery*

Register to watch this free webinar on demand. A link will then be emailed to you shortly after registration. 

This Masterclass is a presentation of the article, [*Bagić AI, Funke ME, Kirsch HE, Tenney JR, Zillgitt AJ, Burgess RC. The 10 Common Evidence-Supported Indications for MEG in Epilepsy Surgery: An Illustrated Compendium. J Clin Neurophysiol. 2020 Nov;37(6):483-497.] supplemented with additional cases and literature review.

This webinar on The 10 Common Evidence-Supported Indications for MEG in Epilepsy Surgery* will be presented by Anto I. Bagić, MD, PhD, FAES, FACNS, Jeffrey R. Tenney, MD, PhD, FACNS, and Andrew J. Zillgitt, DO, FAES, FACNS.

Link to article: https://pubmed.ncbi.nlm.nih.gov/33165222/

Presenter bios:
Anto I. Bagić, MD, PhD, FAES, FACNS

Professor, University of Pittsburgh Medical Center / University of Pittsburgh, Pittsburgh, PA

Jeffrey R. Tenney, MD, PhD, FACNS

Professor, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

Andrew J. Zillgitt, DO, FAES, FACNS

Corewell Health William Beaumont University Hospital, Royal Oak, MI


About the American Clinical MEG Society (ACMEGS)

The paper on which this Masterclass is based was a project of the American Clinical MEG Society, published in the November 2020 issue of the Journal of Clinical Neurophysiology, which was a topical issue devoted to updates in Clinical Magenetoencephalography.

ACMEGS supports MEG centers in delivering quality comprehensive care to people with neurological disorders, by setting standards of care, advocating for access to high quality MEG center services, and providing education, knowledge, and other resources to its member centers.

ACMEGS does not endorse MEGIN or any other MEG vendor nor any specific product.



*MEGIN does not endorse any applications or treatments mentioned at this event. TRIUX™ neo is available for sale in the European Union, UK, Japan, Canada, the United States, as well as certain other countries. In other geographical areas, contact your local MEGIN representative. TRIUX™  neo is intended for use as a magnetoencephalographic (MEG) device that non-invasively detects and displays biomagnetic signals produced by electrically active nerve tissue in the brain. When interpreted by a trained clinician, the data enhances the diagnostic capability by providing useful information about the location relative to the brain anatomy of active nerve tissue responsible for critical brain functions. All other applications are research in nature.

*By submitting your information to register for this talk, MEGIN will use it to communicate with you regarding this event and other services.